Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
B. Agerer, M. Koblischke, V. Gudipati, M. Smyth, A. Popa, J.-W. Genger, L. Endler, D. M. Florian, V. Muehlgrabner, A. Lercher, P. Gattinger, R. Torralba-Gombau, T. Penz, I. Fae, S. Wenda, , A. Bergthaler
The paper identifies mutations in SARS-CoV-2 that reduce MHC-I binding and CD8+ T cell recognition, suggesting escape from immune surveillance.
bioRxiv · Dec 18, 2020 · PreprintImmunology
A. Popa, J.-W. Genger, M. Nicholson, T. Penz, D. Schmid, S. W. Aberle, B. Agerer, A. Lercher, L. Endler, H. Colaco, M. Smyth, M. Schuster, M. Grau, F. Martinez Jimenez, O. Pich, , A. Bergthaler
This study analyzes SARS-CoV-2 superspreading events in Austria using genomic and epidemiological data to understand viral transmission and mutation dynamics.
Science Translational Medicine · Dec 9, 2020Peer-reviewedMicrobiology
A. F. Rendeiro, T. Krausgruber, N. Fortelny, F. Zhao, T. Penz, M. Farlik, L. C. Schuster, A. Nemc, S. Tasnady, M. Reti, Z. Matrai, D. Alpar, C. Bodor, C. Schmidl, C. Bock
This study maps chromatin changes and single-cell immune profiles during ibrutinib treatment in CLL, identifying a shared regulatory program and patient-specific response dynamics.
bioRxiv · Apr 3, 2019Cancer Biology
J. Griss, W. Bauer, C. Wagner, M. Maurer-Granofszky, M. Simon, M. Chen, P. Steinberger, K. Grabmeier-Pfistershammer, F. Roka, T. Penz, C. Bock, G. Zhang, M. Herlyn, K. Glatz, H. Laubli, , S. N. Wagner
bioRxiv · Jan 10, 2019Cancer Biology
S. Sdelci, A. Rendeiro, P. Rathert, G. Hofstaetter, A. Ringler, H. P. Moll, W. You, K. Klavins, B. Guertl, M. Farlik, S. Schick, F. Klepsch, M. Oldach, P. Buphamalai, F. Schischlik, , S. Kubicek
This study identifies MTHFD1 as a genetic and physical interactor of BRD4, linking folate metabolism to transcriptional regulation and showing synergistic effects on cancer cell viability.
bioRxiv · Oct 10, 2018Cancer Biology